Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer

Background: Anti-programmed death 1 receptor (PD-1) therapy is a promising treatment strategy for patients with unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer. However, its response rate and survival benefits are still limited; an immunological analysis of the re...

Полное описание

Библиографические подробности

Главные авторы:	Hajime Matsuida, Kosaku Mimura, Shotaro Nakajima, Katsuharu Saito, Sohei Hayashishita, Chiaki Takiguchi, Azuma Nirei, Tomohiro Kikuchi, Hiroyuki Hanayama, Hirokazu Okayama, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Koji Kono
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2025-08-01
Серии:	Cells
Предметы:	anti-PD-1 therapy gastric/gastroesophageal cancer tumor resection tumor immune microenvironment HLA class I TGF-β
Online-ссылка:	https://www.mdpi.com/2073-4409/14/15/1212
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!